Pharma Journalist

2nd Annual Hemophilia Drug Development Summit
2019-08-20 - 2019-08-22 | Wyndham Boston Beacon Hill, 5 Blossom St, Boston, MA, 02114, United States
Given the excitement and anticipation of increasingly more promising prophylactic treatments and gene therapies, the 2nd Annual Hemophilia Drug Development Summit, once again unites leading pharma, biotech and academic KOLs working to translate and clinically develop longer acting and more efficacious therapies to overcome significant unmet medical need and hemophilia and other bleeding disorders.

Attend the 2nd Hemophilia Drug Development Summit to identify novel drug development strategies and overcome the shared translational, clinical development and delivery challenges to dramatically improve patient outcomes.
Sounds interesting? Find out more – get free event brochure here: https://ter.li/4snxn9

B3DD Summit
2019-08-13 - 2019-08-15 | Wyndham Boston Beacon Hill, 5 Blossom St, Boston, MA, 02114, United States
The Blood-Brain Barrier Delivery Summit (B3DD) is the industry’s first conference dedicated to addressing the translational challenges of effective and safe delivery of CNS drug candidates.

With an emphasis on biologics, and built with the field’s leading minds from the likes of Biogen, Genentech, Armagen & Denali, the B3DD Summit will unite over 60 industry stakeholders giving you the opportunity to develop new partnerships and build on existing relationships to ensure you have the connections to accelerate your drug’s development.
Some of the highlights include:

Assessing Microphysiological Models of the BBB – Biogen
Employing in vivo Microdialysis & Microperfusion Methods to Understand Brain Disposition of Biologics for the Treatment of CNS Disorders – AbbVie
Clinical Efficacy of Antibody-enzyme Fusion Proteins as Carrier Platform to Transport Lysosomal Enzymes Across the BBB for the Treatment of Mucopolysaccharidosis Type I
PKPD of Different Therapeutic Modalities for CNS Indications – Genentech
Explaining Clinical Failures – Is Efficacy or Delivery to Blame?- Merck, Lundbeck, AbbVie

To learn more about B3DD Summit, and to register online, visit https://ter.li/7vs04e

2nd Neuropsychiatric Drug Development Summit
2019-07-23 - 2019-07-25 | Wyndham Boston Beacon Hill, 5 Blossom St, Boston, MA, 02114, United States
THE INDUSTRY’S DEFINITIVE MEETING TO ADVANCE THE DEVELOPMENT OF CLINICALLY TRANSFORMATIVE NEUROPSYCHIATRIC DRUGS

With the huge unmet clinical need in neuropsychiatry and despite multiple approved pharmaceuticals available, the development of the next generation of neuropsychiatric drugs is essential.
The abundance of excitement and scientific progress in the field – especially with the recent approval of esketamine – will be captured at the Neuropsychiatric Drug Development summit, in Boston on July 23 – 25, 2019.
Built with thought-leaders at Sage Therapeutics, Johnson & Johnson and Lundbeck, the 2nd Annual NPD summit will unravel the complexities of developing truly clinically transformative neuropsychiatric drugs.
Dedicated to overcoming challenges in neuropsychiatric drug development, this comprehensive discussion and networking forum will cover:

Reviewing the current clinical landscape to share learned lessons, predict potential success and identify future opportunities
Determine what we can expect from neuropsychiatric preclinical models to better predict clinical efficacy
Utilize what we know from the clinical to improve our use of translational strategies
Discuss the potential for digital therapeutics to transform the success of efficacious pharmaceuticals
Review symptomatic focused drug development to identify the benefits and impact future regulation
Evaluate the potential for different neuropsychiatric targets by improving our understanding of neuropsychiatric biology
Improving our understanding of the role of genetics in neuropsychiatry and debating the future of precision medicine for neuropsychiatric disorders

Join your peers at NPD to be part of the cross-industry discussion on latest developments, insights and science to elevate clinically effective neuropsychiatric therapeutic pipelines
To learn more about this event, visit https://ter.li/belugv

IMPACCT: mHealth in Clinical Trials Summit
2019-07-16 - 2019-07-18 | The Westin Copley Place Boston, 10 Huntington Ave, Boston, MA, United States
The IMPACCT: mHealth in Clinical Trials series provides a dedicated forum for industry leaders in clinical and digital innovation to share data, best practice and game-changing approaches on how to transform the clinical research paradigm with digital technology and achieve true patient-centricity.
Join your peers and leading experts in this space for a collaborative discussion aiming to tackle key implementation challenges and accelerate the successful incorporation of innovative digital strategies in clinical R&D, to enhance patient experience and outcomes.
Industry leaders already confirmed include Novartis, AbbVie, the DiMe Society, Verily & many others.

PREDiCT: Tumor Models Boston
2019-07-16 - 2019-07-18 | Revere Hotel Boston Common, 200 Stuart Street, Boston, 02116, United States
The 7th Annual PREDiCT: Tumor Models Boston summit will explore robust preclinical strategies utilizing current and emerging model systems to overcome core challenges across the early stages of cancer drug development. Presentations will span preclinical strategies validating new anticancer drugs, assessing therapeutic index and identifying surrogate markers of tumor progression.

Plug into a network of preclinical and translational scientists seeking to share methods for the rational design of combinations, patient stratification and identify new strategies to model metastasis, resistance and sensitivity.
Why attend PREDiCT : Tumor Models Boston ?

35+ Preclinical & Translational Oncology Heads, each pioneering the further development and application of experimental models, will be sharing the latest insights on the impact of their work.
100+ senior level scientists from Sanofi, Kleo Pharmaceuticals, NIH, Dicerna, Pfizer, Crown Bioscience, The Jackson Laboratory, Eisai and many more are set to review the comparative cost-per-data point of next generation models alongside classical model-systems.
We’ll explore how classical and emerging models are evolving efficacy determination, biomarker discovery and combination therapies, allowing you to further develop your research and gain the best insight of the industry.

Download the full event guide to find out more!
To learn more about this event, and to register online, visit https://tumor-models.com/

Indian Pharma Expo & Business Excellence Award 2019
2019-07-16 - 2019-07-18 | Hall no. 12-A, Pragati Maidan, New Delhi, Delhi, India
CIMS Medica presents the 8th edition of Indian Pharma Expo (IPE), scheduled to be held on 16th-18th July, 2019 at Hall No. 12-A, Pragati Maidan, New Delhi.

Previous year IPE set another successful milestone with presence of visitors from all parts of India and provided a common platform for promising sellers and potential buyers from Pharmaceutical and Healthcare Industries. With IPE, the benefits are bound to get augmented with presence of eminent personalities from various sectors of Pharma, non-pharma and healthcare industries. It will gather representation from various companies like Pharmaceutical manufacturers & marketers, packaging solution providers, machinery solution providers, franchise companies and many more under one roof.
The 3-day expo will bring together eminent personalities from various sectors of Pharmaceutical, non-pharma and healthcare industries. IPE 2019 is one stop juncture to all those who are planning to expand their business through various channels of franchise and distribution; as well as wholesalers and hospital purchase personnel who seek to buy bulk products on concessional rates.
This year IPE will be one point contact to exchange the business opportunities for National and International Pharmaceutical Companies. This event will prove to be a business expansion tool to many small-medium-major players in Pharmaceutical Industry.

Clinical Operations in Oncology Trials to East Coast 2019
2019-07-10 - 2019-07-11 | Boston, Massachusetts
Arena International is excited to announce the return of the 7th Annual Clinical Operations in Oncology Trials to the East Coast on July 10th-July 11th 2019.
As one of the only oncology operationally focused events in the East Coast, this meeting will aim to provide strategies to allow for operationally meaningful and targeted oncology trials to engage East Coast physicians and patients.
The event will be led by a myriad of industry specialists from the East Coast who will deliver solution and strategy through a variety of interactive formats: panel discussion, spotlight Q&As, roundtables and more! This conference will also provide a platform for industry professionals to network with some of the most innovative vendors in the market.
While maintaining the primary focus of its previous years, our 2019 event will look at how to prepare for the ever-changing dynamic of the oncology industry, and provide insight into the latest technological and therapeutic solutions.
This July prepare to hear from industry leading oncologists about accurate abidance to ICH E8 guidelines, effective oversight strategies, efficient trial designs and data management solutions. As pharmaceutical companies shift to conducting immuno-oncology trials and look towards how AI, data analytics and cutting edge technology can aid with early diagnosis, take this opportunity to stay updated with industry trends and showcase your innovative solutions to key decision makers.
We hope to see you in July, make sure to register your place today!

The Pharma Gorilla
2019-06-26 | Le Meridien Singapore, Sentosa
After a successful and overwhelming response of the Pharma Gorilla conference Mumbai on March 27, The Conference Gorilla is organizing its 2nd and 3rd Edition of The Pharma on following dates and venues.

The Pharma Gorilla | June 26, 2019 | Le Meridien Singapore, Sentosa
The Pharma Gorilla | Nov 07, 2019 | New Delhi, India

The objective of this conference to share expertise addressing the current advancements involved in the Pharmaceutical industry. The knowledgeable intriguing sessions will create an ideal platform to get acquainted with the latest trends, advancements, and future of the pharmaceutical sciences. It is a wonderful opportunity for all the participants as it provides a networking opportunity to collaborate with the world class Pharmaceutical and healthcare industry.
The conference program have been designed in such way which can cover the trending topics under Keynote session, exclusive presentation, product lunch, panel and round table discussion and it also provides a meaningful information.
The Pharma Gorilla provides a perfect platform for conducting presentations, keynote sessions, sharing the knowledge, one on one meeting with your potential audience and getting acquainted with the latest developments in the pharmaceutical and healthcare industry to stand out of the competition.
Target Audience: 150+ Pharma professional from all over the Asia so I think it would be a good platform for you to accomplish your networking with the key decision makers of pharmaceutical companies, software development companies, CRO, manufacturing, formulation, digital marketing and data management companies.
Glimpse of Conference Agenda!
Conference Panels

Artificial Intelligence in Pharma and Healthcare
A disruptive take on marketing: Digital Marketing comes to Pharma
Scope of E-Pharmacy in Asia: Bringing New Dimensions to Pharma Industry
Latest Trends in Formulation Development: A Global Perspective
The Impact of Regulatory Reform on Innovation in Drug Delivery Systems

Roundtable Discussion

Improving patient engagement and experience to improve clinical trials

Keynote Session

Innovation-driven and emerging technologies of Pharma Industry in Asia
The Global Pharma Industry: Policies, Regulations and Key Trends 2019-2020

Exclusive Presentation

Role of IPR in pharmaceutical industry
Career Growth Opportunities in the pharmaceutical industry
Improving Biosimilars in manufacturing data

For any query, contact us at contact@theconferencegorilla.com or IN: +91-813-004-7071 | US: +1-347-480-1588

4th Microbiome Movement – Drug Development Summit
2019-06-26 - 2019-06-28 | Revere Boston Common Hotel, 200 Stuart Street, Boston, MA, 02116, United States
4th Microbiome Movement – Drug Development Summit
June 26-28, 2019 | Boston, MA

Returning for the fourth year, the Microbiome Movement – Drug Development Summit continues to be the industry-leading forum to help forward thinking researchers from the pharmaceutical, biotech and academic community pursue the causal role of the human microbiome in disease, to create a new generation of targeted treatments that demonstrate consistent clinical outcomes and predictable MoAs.
If you are, or would like to be, a player in the microbiome arena, this is the conference you should attend to not only hear the latest pre-clinical and clinical development from organizations developing microbiome-based therapeutics, biomarkers and diagnostics, but also make long-lasting connections that will accelerate your microbiome developments forward, and help translate this promising science into a reality for patients.
Hear from 60+ expert speakers including:

Alison Lawton, CEO, Kaleido Biosciences
Bernat Olle, CEO, Vedanta Biosciences
Cathryn Nagler, Bunning Food Allergy Professor, University of Chicago
Eric Shaff, CEO, Seres Therapeutics
Esi Lamouse-Smith, Director, Janssen Pharmaceuticals
Ken Blount, CSO, Rebiotix
Mike Romanos, CEO, Microbiotica
Ulrich Thienel, Chief Medical Officer, Finch Therapeutics Group

See the complete agenda and speaker list: https://ter.li/nefsqj
Early booking rates and group discounts are available. Visit the website to learn more: https://ter.li/1bcb5n.

Cell Engager Summit
2019-06-25 - 2019-06-27 | Revere Hotel Boston Common, 200 Stuart Street, Boston, MA, 02116, United States
The Cell Engager Summit is the only meeting focused on developing multi-specific cell engaging therapies in liquid and solid tumor indications; accelerating early discovery innovation into the clinic.

Overcome safety and toxicity challenges by increasing target specificity and improved cellular trafficking through informed target selection to ensure enhanced efficacy of your cell engager drug.
Discover how to effectively scale complicated manufacturing of multispecific cell engagers to reduce production costs and time whilst ensuring purity and quality of antibodies.
With 22+ hours of content, 2 interactive workshops and over 5 hours of networking with key industry leaders, this conference will focus solely on cell engaging drugs and how to tackle key clinical and commercial challenges.
Join us as we unite experts from across large pharma, innovative biotech and solution and service providers to bring to market safe and effective multi-specific immune cell engaging therapies.
To learn more and to register online, visit cell-engager-summit.com

2nd Combination Products Lifecycle Management Summit
2019-06-25 - 2019-06-27 | Hyatt Regency Boston, One Ave. de Lafayette, Boston, MA, 02111, United States
Returning to Boston for its 2nd successful year in 2019, the CPLM Summit features a fresh speaker line-up including the FDA, Alnylam, kaleo, Novartis and many others, as well as a pre-conference focus day to give you a comprehensive LCM guide to your combination products.

Lifecycle management for drug-device combination product has stolen the spotlight amongst pharma, biotechs and device developers. Integrating multiple project teams and defining a common LCM program can be difficult – but there is a lot of potential and many benefits to having such a mind-set and implementing a robust LCM program from the get-go.
As the only peer-led community, we will bring in 100+ senior leaders from drug-device teams including the regulatory affairs, product development and quality to share their view and encourage collaborative efforts.
For more information on 2nd Annual CPLM Summit, visit https://ter.li/11hr26

GI Inflammatory Diseases Summit (GIIDS)
2019-06-24 - 2019-06-26 | Revere Hotel Boston Common 200 Stuart Street Boston, MA, 02116 USA, MA, United States
Developing More Clinically Safe & Efficacious Therapeutics for GI Inflammatory Diseases
The GI Inflammatory Diseases Summit (GIIDS) focuses exclusively on overcoming translational drug development challenges to achieve more clinically safe and efficacious therapeutics for Inflammatory Bowel Disease.
Incorporating insights from leading pharma and pioneering biotech, this discussion and networking forum will curate the cutting edge insights on:

Improving drug safety profiles of more gut-selective compounds
Optimizing trial design in a hypercompetitive market
The promise of microbiome based biotherapeutics

Join gastroenterology, immunology and anti-inflammatory drug developers at this unique conference and push the clinical frontier nearer to achieving significant clinical remission in larger groups of patients.

8th Annual HPAPI Summit
2019-06-19 - 2019-06-21 | The Westin Waltham Boston 70, Third Avenue Waltham,Boston Massachusetts 02451
Enabling Robust, Safe and Cost-Effective Productionof Highly Potent APIs
In the context of ever-increasing drug potency, the 8th Annual HPAPI Summit will provide you with real-world case-studies from the companies actively working with these compounds, enabling you to implement safe and robust practices in your own organization.
Incorporating insights from Genentech, Pfizer, Boehringer Ingelheim, SafeBridge and AbbVie, you will leave this conference with actionable insights that will enable you to produce highly potent APIs more robustly, safely and cost-effectively.

CPhI & P-MEC China 2019
2019-06-18 - 2019-06-20 | SNIEC, Shanghai, China
As the most comprehensive pharmaceutical exhibition in Asia, CPhI & P-MEC China has, since its launch in 2001, been fostering international pharmaceutical business exchanges and leading market trends and technical innovations in the entire industry. Based in Shanghai and with a global vision, CPhI & P-MEC China is emanating its influences by creating a trading & sourcing platform, gathering quality suppliers, sharing cutting-edge knowledge, and building up an elite pharma professional network.

CPhI & P-MEC China 2019 will be held in Shanghai on June 18-20, 2019. The annual pharma gala are expected to gather 70,000+ visits and showcase 3,200+ exhibitors in a 200,000+ square metre space. Welcome to join us in CPhI & P-MEC China 2019!

To learn more and to register online, visit: http://bit.ly/2r8jnuD

Clinical Trial Supply Southern California 2019
2019-06-05 - 2019-06-06 | Marriot Del Mar, San Diego, California
Facilitating a platform for the San Diego biotech hub to refine their clinical trial supply strategy to remain patient focused whilst staying at the forefront of an ever-changing landscape.
2019 will celebrate the 9th year Arena International brings the global Clinical Trial Supply series to San Diego, giving decision makers from small, medium and large pharmaceutical companies the opportunity to as inject agility, transparency and speed into your clinical trial supply.
This event brings the unique San Diego biotech hub together to discuss the best methodologies for ensuring successful clinical trial supply. We will focus on the full supply chain, starting with the front end all the way to site and direct to patient delivery. Delving into the finer details we will ensure the smooth running of trial supplies, to not only start and finish on time, but also to meet budgetary constraints.
Avoiding death by power point our 2 day event will facilitate interactive and engaging sessions from panel discussions, roundtables, fireside chats and case studies to give rise to innovation solutions to existing challenges.
The key topics to be addressed will be:

Forecasting and Planning
Packaging and Labelling
Unique trial design e.g. adaptive, compassionate use and at home delivery
Brexit
New technologies

Join us in June in San Diego to be a part of the discussions and develop unique insight for clinical trial supply.

Digital Pharma Europe
2019-06-04 - 2019-06-06 | Merck Serono Headquarters, Via Casilina 125, Rome, 00176, Italy
The 11th Digital Pharma Europe, hosted by Meck Serono in Rome, will focus on helping pharma understand how to evolve and adapt to the rapidly changing global healthcare ecosystem, and to the rapidly changing needs and dynamics of its customers. In essence: Understand Digital Marketing and the Evolution of The Engagement Model In The Era of AI.
To learn more about this event, and to register online, visit http://bit.ly/2UrQr1e

Lyophilisation
2019-06-03 - 2019-06-04 | Holiday Inn Kensington Forum, 97 Cromwell Road, London, SW7 4DN, United Kingdom
SMi Presents their 7th Annual Lyophilisation Conference
SMi Group announces the return of the 7th Annual Lyophilisation Conference taking place on the 3rd and 4th June 2019, in London, UK.

Lyophilisation (or freeze drying) remains one of the most exciting and rapidly advancing technologies in the pharmaceutical industry to date. By 2020, the lyophilisation equipment market is projected to exceed 8% CAGR reaching approximately £4.4 billion.
Attend this conference along with key opinion leaders from all areas of pharmaceuticals and biologicals to explore formulation science, materials characterisation, novel and alternative technologies, mathematical modelling and regulatory updates.
How Will You Benefit?
Network and learn from leading professionals such as:
CHAIRS FOR 2019
Sune Klint Andersen, Principal Spray Drying, Janssen Pharmaceuticals
Xiaodong Chen, Senior Research Investigator, Bristol-Myers Squibb
KEY SPEAKERS INCLUDE:

Paul Matejtschuk, Principal Scientist & Section Head, Standardisation Science, NIBSC
Davide Fissore, Associate Professor, Politecnico di Torino
Michael Dekner, Head Fill & Finish LCM support, Takeda
Richard Denk, Head Sales Containment, Skan AG
Mostafa Nakach, Head of Pharmaceutical Engineering Group, Sanofi-Aventis R&D
Daryl Williams, Professor of Particle Science and Director of Discovery space, Imperial College London
Kevin Ward, Director of R&D, Biopharma technology
Paul Barry, Development Scientist, Genzyme Ireland Ltd/Sanofi

2019 HIGHLIGHTS

Explore the recent advances in lyophilisation methods and technologies from Biopharma Technology
Discuss the novel methods that characterise complex pharmaceutical products to aid formulation design from NIBSC
Gain insight into the approaches to avoid cross contamination during lyophilisation from SKAN AG
Discover a new approach towards process design through the use of micro freeze dryers by Politecno di Torino
Examine the use of model-based approach to lyophilisation cycle design from Takeda

For more information on 7th Annual Lyophilisation Conference, visit: www.lyophilisation-europe.com/PJ
Early-Bird Rates

BOOK BY 29TH MARCH AND SAVE £400
BOOK BY 30TH APRIL AND SAVE £200
BOOK BY 31ST MAY AND SAVE £100

Contact Info
T: +44 (0) 20 7827 6164
E: nhoward@smi-online.co.uk

Skin Microbiome Congress
2019-05-29 - 2019-05-30 | Revere Hotel Boston Common, 200 Stuart St, Boston, MA, 02116, United States
Skin Microbiome Congress
Revere Hotel Boston Common 200 Stuart St, Boston, MA 02116, USA
29 – 30 May, 2019
“Skin microbiome today is exploding with companies all over the world. Now we’re at a point where the awareness is so great that there’s almost like a tidal wave of interest in microbiome!” – Mike Conti, Solabia

2018 saw the microbiome move to the forefront of over 300 industry leaders, who came together to exchange ideas at our Global Skin Microbiome Congress Series, the first dedicated congress focusing solely on Skin Microbiome.
With the microbiome set to be the biggest trend in skincare for 2019, we are incredibly excited to bring our flagship congress back to Boston, building on our success globally and connecting over 300 industry leaders.
This year, we take a deep-dive into the two key areas critical for success in this in this evolving field, with our 2 concurrent tracks of content. Track 1 will focus on developing a functional understanding of the microbiome, whereas track 2 will be focusing on building a commercial viable business.
Don’t miss the opportunity to join leading industry experts to explore next steps for skin microbiome research and development, as well as commercialization.
The inaugural Skin Microbiome Congress in 2018 SOLD OUT, don’t miss your chance to attend this year’s event!
To learn more about Skin Microbiome Congress, and to register online, visit www.skinmicrobiomecongress.com

Healthcare Market Access & Pricing World Summit
2019-05-28 - 2019-05-29 | NH Frankfurt Airport West Kelsterbacher Str. 19, 65479 Germany
The 2nd annual Healthcare Market Access & Pricing Summit is the meeting place for the Healthcare Pricing, Market Access, Reimbursement, HEOR, and RWE community.
Senior level experts from companies such as Abbott, Merck, Allergan, and Johnson & Johnson among others will give you valuable insights through various interactive sessions.
With hot session topics like biosimilars, orphan drugs and rare diseases, this conference will provide a total and complete insight into the latest developments in the healthcare space, may it be Pharma, MedTech, Biopharma or Biotech.
Join over 60+ healthcare professionals in May, and book your ticket now!

Microbiome Invest
2019-05-23 | London (Venue TBC)
Microbiome Invest 2019 is dedicated to showcasing the most innovative emerging companies and academics with commercially viable research that manipulates the microbiome. Active investors, and multi-national nutrition and pharmaceutical companies will also share their knowledge and perspectives on commercialisation and discuss the most cutting-edge products and research in the microbiome space.

RE•WORK Deep Learning in Healthcare Summit, Boston
2019-05-23 - 2019-05-24 | InterContinental® Boston, 510 Atlantic Avenue, Massachusetts 02210
The Deep Learning in Healthcare Summit is returning to the east coast for the annual event in Boston! Hear from healthcare industry leaders, academics, researchers, and innovative startups working to advance deep learning technology and apply this within the health sector. Focusing on topics such as medical imaging, diagnostics, personalized medicine and how these are applied within pharmaceuticals, patient care, and health and wellbeing. The summit is a great way to discover the latest insights, evaluate your position within the industry and learn how the impacts can affect yourself and your work and provides an opportunity to network with other valued members of the community.
Discount Code: MP20

5th Precision CRISPR Genome Editing Congress
2019-05-21 - 2019-05-23 | The Westin Boston Waterfront, 425 Summer Street, Boston, MA, 02210, United States
Designed with CRISPR experts from AstraZeneca, AbbVie, Broad Institute, Casebia, Merck, Amgen and academics worldwide, this years 5th Precision CRISPR Genome Editing Congress encapsulates the critical scientific challenges and opportunities of CRISPR applications with regards to delivery, safety, precision, and efficiency to further optimize the relevant areas of drug discovery, functional screening & CRISPR-based cell & gene therapy.

Learn about how CRISPR is working in a clinical setting and unique approaches to gene therapy
Discover advances in disease modeling and strategies improving validation of human biology
Understand how we are harnessing novel CRISPR systems and the resulting expansion of the molecular toolbox
Explore how base editing is set to be the best technique for precision genome editing and the consequent applications in both basic biology and genetic diseases
Discover the wealth of CRISPR screening techniques available and how to implement them into your own drug discovery pipeline
Participate in forward-thinking debates and discussions crucial to advancing the infinite possibilities of CRISPR

With 100+ thought-leaders converging, this will surely be an unrivaled opportunity for you to gain the latest scientific insights into the ever-evolving CRISPR landscape and grow your collaborator network.
To learn more about this event, visit https://ter.li/tjkmgn

NDD Europe 2019
2019-05-21 - 2019-05-23 | Hilton Paris La Defense, 2 Place de la Défense, 92800, Puteaux, France, France
Overcome Translational Challenges Preventing the Development of Clinically Effective Neurodegenerative Therapeutics

Multiple clinical failures in the neurodegenerative field have sparked realisation that there is a critical need for discussion and debate between neurodegenerative drug developers to drive clinical success.
NDD Europe will overcome the translational challenges facing neurodegenerative drug developers by exploring the future biomarkers of neurodegeneration, improving preclinical modelling to increase clinical predictability and encouraging precompetitive strategies and collaboration amongst drug developers.
With 70+ thought-leaders converging at NDD Europe, this will be an unrivalled opportunity for you to gain the latest scientific insights, have your peers review your research and grow your collaborator network.

3rd Annual Digi-Tech Pharma 2019
2019-05-21 - 2019-05-22 | London, United Kingdom
Our upcoming conference 3rd Annual Digi-Tech Pharma 2019 (Pharmaceutical technology conference 2019), will provide a platform to all its participants an opportunity to interact, share and discuss the digitalization of Pharma industry. The conference will allow its participants to discuss the various challenges faced, new strategies, case studies and use of innovative ideas in the field of Digital Pharma IT. Also, to stay updated on the latest trends in digital, social media and mobile strategies required to overcome the obstructions in the transformation. This Digi-Tech Pharma 2019 is a unique platform in the pharmaceutical conferences which will allow IT leaders to share their technologies and strategies to help the pharma industries avail new opportunities to encourage partnerships and collaborations.

TIDES: Oligonucleotide & Peptide Therapeutics
2019-05-20 - 2019-05-23 | Manchester Grand Hyatt | San Diego, CA
TIDES is the world’s largest meeting to accelerate oligonucleotide and peptide products from early discovery to late-stage development & commercialization.

1000+ Oligonucleotide & Peptide Scientists and Executives
Fast-track your oligonucleotide and peptide research to the clinic and beyond by collaborating with leading pharma, biotechs, academia and solution providers from North America, Asia and Europe.
90+ Exhibitors
Connect with leading manufacturing, technologies, and service providers to drive your promising therapeutic towards commercial success.
125+ Case Studies and New Data Presentations
Hear best practices, lessons learned and important industry developments across the entire spectrum of oligonucleotide and peptide development and production.
Register now at www.TIDESEvent.com with code “PHARMJ10” and SAVE 10%.

Plant Genomics and Gene Editing Congress: Europe
2019-05-20 - 2019-05-22 | Rotterdam, The Netherlands Postilion Convention Centre WTC Rotterdam, Rotterdam, Netherlands
Global Engage is pleased to announce the 7th Plant Genomics & Gene Editing Congress: Europe, taking place 21st-22nd May 2019, in Rotterdam, The Netherlands. This event is part of our widely-regarded Plant Genomics Series which includes an Asian and US meeting each year.
Attracting over 300 experts working in all areas of plant science, this event will examine the latest in gene editing methods for plant genomics research. CRISPR/Cas9 case studies and the very best strategies for plant genome engineering will be presented by industry leaders, experts, and pioneering academics at the forefront of plant research. Developments in gene editing, NGS, and omic technologies will all be explored for crop trait development, disease resistance, epigenetics, plant breeding, and more. Tracks dedicated to plant & soil microbiomes, and the importance of plant phenotyping in the context of bioinformatics challenges, will encourage a holistic approach to plant research; the former will focus on identifying microbes to enhance crop productivity & disease resistance, while the latter will showcase the best tools for overcoming bioinformatics bottlenecks, applicable to plant research across the board. We will also be looking to examine the impact of the ECJ’s latest interpretation of GMO regulations, and what this means for the future of gene editing research, addressing issues such as how to navigate the new legislation, and considering what alternative strategies & technologies there might be for progressing plant genomics.

Microbiome & Probiotics Series: Europe
2019-05-20 - 2019-05-22 | Rotterdam, The Netherlands Postilion Convention Centre WTC Rotterdam, Rotterdam, Netherlands
Part of the leading global microbiome and probiotics conference series, the 2019 European event will bring together more than 400 industry, academic, and investment leaders to discuss the must cutting-edge microbiome and probiotics research, challenges and opportunities in moving research towards commercialisation, and potential partnerships and collaborations.
For the first time, this event will be three days. As an attendee, you will get more in-depth content on the key challenges and topics facing researchers and product developers, and more time to establish partnerships. Hear from top scientists in the field, meet willing investors and collaborators, and learn about exciting new companies in the microbiome space. With ample networking time and interactive sessions like the roundtable discussions, there will be many opportunities to broaden your connections.

Global Bioprocessing, Bioanalytics and ATMP Manufacturing Congress
2019-05-20 - 2019-05-21 | Dublin, Ireland, Hotel Riu Plaza The Gresham Dublin, Dublin, Ireland
This comprehensive two-day congress features 30 presentations given across four tracks. It will provide experts with an exceptional environment in which to examine the key developments occurring today. Topics covered includethe automation of vaccine formulations, purification technologies, T-cell manufacturing and glycoanalytic technologies.

SMi Presents the 2nd Annual Conference: Injectable Drug Delivery 2019
2019-05-15 - 2019-05-16 | Copthorne Tara Hotel London Kensington, Copthorne Tara Hotel London Kensington, London, SW7 4DN, United Kingdom
The SMi Group is pleased to announce the second annual Injectable Drug Delivery conference which will be held in London on the 15th and 16th May 2019.
The global injectable drug delivery market is expected to grow from $400 billion to $1200 billion by 2046 with a CAGR of 12.8%.

Injectable drug delivery is a method of drug administration into the body with a needle via various routes including intramuscular and intravenous. These are examples of conventional drug delivery. Recently, there has been a focus on novel drug delivery, including needle-free injectors, and transdermal patches. Long acting injectables (LAI) are developing fast as a push towards patient centric devices drives the industry. Habitually, injectables were used for delivery of hormones, vaccines and insulin but as technology advances the application is continuing to expand. Now there is an emphasis on finding solutions to chronic conditions and the biological drugs required involve formulation development challenges for proteins, including high viscosity and high volume. Self-administrative, connected, and ergonomic devices are the new drive. Self-injectable devices include pen injectors for diabetic patients. The wealth of expansion available in the field of connected devices is huge. The regulatory landscape is challenging as it evolves rapidly with the market demand for new devices.
The benefits of attending:
Developing on last year’s success, this event assembles an international audience to include regulatory, device design, packaging and formulation professionals. The devices need to be designed for the new generation of drugs and they need to provide safety with a strong patient focus. This event is will help inspire you to help drive this industry forward and learn about the predicted market trends, critical digital and chemical developments and the push for patient compliance in a changing regulatory landscape.
This conference offers a chance to learn about innovative injectable drug delivery systems with industrial insights on the following:
– Life cycle management for developing devices that are both user friendly and revenue effective
– Device design considerations
– Long acting injectables and bringing these therapeutics to market with case studies
– Connected devices, GDPR and cyber security programs
– Developments in primary packaging
– Growth in transdermal delivery and subcutaneous infusion devices
– Digital health partnerships
– Large volume patch pump innovation examples
Who should attend
Executives, Directors, VPs, Heads, Principals, Managers, Scientists, Researchers of:

Autoinjectors
Wearables
Device Engineering
Human Factors
CMC
Injectables
Sterile Manufacturing
Packaging
Regulatory Affairs

Featured Speakers:

Bjorg K. Hunter, Device Engineering Manager, GSK
Miranda Newbery, Human Factors Consultant, Inspired Usability
Blake Green, Regulatory Affairs Senior Manager, Devices, Amgen
Quentin Le Masne, Head of Engineering team – Electro-Medical / Drug Delivery Devices, Merck
Vasco Filipe, Formulation and Drug Process Development Section Head for Biologics, Sanofi
Stephen Paboojian, Senior Project Leader I for Device Development, Novartis
Tom Lawrie-Fussey, Digital Services Specialist, Cambridge Design Partnership
Terry Reed, Director of Business development, AstraZeneca
Joel Richard, Head of Technical and Pharmaceutical Operations, MedinCell

*Plus, pre-conference workshops – 14th May 2019
EARLY-BIRD RATES:

BOOK BY 31st JANUARY AND SAVE £400
BOOK BY 28th FEBRUARY AND SAVE £200
BOOK BY 29th MARCH AND SAVE £100

LinkedIn: @SMi Pharma
Twitter: @SMiPharm #SMi
To learn more about this event, and to register online, visit www.injectable-drug-delivery.com/pharmajwl

GLOBAL CLINICAL TRIALS CONNECT 2018 (Collaboration, Innovation And Enhancing Quality In Clinical Trials )
2019-05-08 - 2019-05-09 | London, United Kingdom
The Global Clinical Trials Connect 2019 conference focuses on introducing pioneer technology, developing better patient engagement and collaborating strategies in clinical trials. With the right commitment and attention to detail, contract research organizations (CROs) and pharmaceutical companies can drive collaboration with greater efficiency. This conference will bring together the industry experts and leaders across pharmaceutical, biotechnological and CRO’s for brainstorming on Case studies on innovation, collaboration and existing clinical data to headway the Clinical Trials process. Ethical considerations are given in this context and for this RBM are beginning to extend its concepts in Quality Risk Management; clinical trial predictive models are accumulated by enterprises, methodologies in trial design and many more.
